Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.

Autor: Miedema KG, de Bont ES, Elferink RF, van Vliet MJ, Nijhuis CS, Kamps WA, Tissing WJ, Miedema, Karin G E, de Bont, Eveline S J M, Elferink, Rob F M Oude, van Vliet, Michel J, Nijhuis, Claudi S M Oude, Kamps, Willem A, Tissing, Wim J E

Publikováno v: Supportive Care in Cancer; Oct2011, Vol. 19 Issue 10, p1593-1600, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients.

Autor: Hanekamp D; Department of Haematology, VU University Medical Center, Amsterdam, the Netherlands., Denys B; Department of Laboratory Medicine, Haematology, Ghent University Hospital, Ghent, Belgium., Kaspers GJL; Department of Paediatric Oncology/Haematology, VU University Medical Center, Amsterdam, the Netherlands.; Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands., Te Marvelde JG; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Schuurhuis GJ; Department of Haematology, VU University Medical Center, Amsterdam, the Netherlands., De Haas V; Dutch Childhood Oncology Group, The Hague, the Netherlands., De Moerloose B; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., de Bont ES; Department of Paediatric Oncology/Haematology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zwaan CM; Department of Paediatric Oncology/Haematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., de Jong A; Dutch Childhood Oncology Group, The Hague, the Netherlands., Depreter B; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Clinical Biology, Microbiology and Immunology, Ghent University, Ghent, Belgium., Lammens T; Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium., Philippé J; Department of Laboratory Medicine, Haematology, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Clinical Biology, Microbiology and Immunology, Ghent University, Ghent, Belgium., Cloos J; Department of Haematology, VU University Medical Center, Amsterdam, the Netherlands.; Department of Paediatric Oncology/Haematology, VU University Medical Center, Amsterdam, the Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Publikováno v: British journal of haematology [Br J Haematol] 2018 Nov; Vol. 183 (3), pp. 512-516. Date of Electronic Publication: 2017 Oct 26.

High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer.

Autor: Diets IJ; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Waanders E; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Ligtenberg MJ; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van Bladel DAG; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Kamping EJ; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Hoogerbrugge PM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Hopman S; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Olderode-Berends MJ; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Gerkes EH; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Koolen DA; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Marcelis C; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Santen GW; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., van Belzen MJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., Mordaunt D; Department of Genetics and Molecular Pathology, SA Pathology, Women's and Children's Hospital, North Adelaide, Australia., McGregor L; Department of Genetics and Molecular Pathology, SA Pathology, Women's and Children's Hospital, North Adelaide, Australia., Thompson E; Department of Genetics and Molecular Pathology, SA Pathology, Women's and Children's Hospital, North Adelaide, Australia., Kattamis A; First Department of Pediatrics, Athens University Medical School, Athens, Greece., Pastorczak A; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland., Mlynarski W; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland., Ilencikova D; 2nd Pediatric Department, Children's University Hospital, Comenius University, Bratislava, Slovakia., van Silfhout AV; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Gardeitchik T; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., de Bont ES; Department of Pediatric Oncology and Hematology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, the Netherlands., Loeffen J; Department of Pediatric Oncology and Hematology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, the Netherlands., Wagner A; Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, the Netherlands., Mensenkamp AR; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Kuiper RP; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Hoogerbrugge N; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Jongmans MC; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands. Marjolijn.Jongmans@radboudumc.nl.; Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Apr 01; Vol. 24 (7), pp. 1594-1603. Date of Electronic Publication: 2018 Jan 19.